lobbying_activities: 2471689

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2471689	3bccf137-1949-4bbc-ab83-a3eea62e4eb0	3T	HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES	401105685	STONINGTON GLOBAL LLC ON BEHALF OF NOSTRUM PHARMACEUTICALS	2020	third_quarter	HCR	1. Request to CMS/Medicaid to review drug rebate rule in regards to and AMP re-adjustment for Nitrofuratonin OS. 2. Request to CMS to appeal baseline AMP for Nitrofuratonin OS.	White House Office	14000		0	1	2020-07-17T12:33:59.850000-04:00